Watch CBS News

Longer life span for large dogs may soon be possible with new longevity drug

An anti-aging drug for dogs may be on the market as soon as 2026
An anti-aging drug for dogs may be on the market as soon as 2026 00:34

A new drug may be the answer for pet owners who want their dogs to live their best lives and be part of the family for as long as possible,

The veterinary medicine company, Loyal for Dogs, says after four years of testing, it has a longevity drug for dogs that has passed the first step of US Food and Drug Administration approval.

The drug, named LOY-001, is meant for dogs over 7 years old, 40 pounds or more, and would be injected by a veterinarian every three to six months. It is anticipated to be on the market by 2026.

The company's founder, Celina Halioua said her goal was to bring the first lifespan extension drug to market.

 "I'm so proud to announce that Loyal has earned what we believe to be the FDA's first-ever formal acceptance that a drug can be developed and approved to extend lifespan," Halioua said.

The drug underwent a four-year testing period before the recent FDA first-step approval, according to Halioua. 

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.